Pharmaceutical Executive
April 24, 2014
Features
0
0
Four commercial line executives serve as our jury of peers on what's in store for the future of pharma, and discuss the changing criteria for market success, from drugs to consumer products to vaccines.
April 22, 2014
Column
0
0
Ben Comer reports on how new pipeline therapies, public research investments, and a renewed sociopolitical focus are working toward a happier outcome for sickle cell disease patients.
April 16, 2014
Features
0
0
California's Bay Area and the Boston/Cambridge nexus continue to dominate bioinnovation in the US. Pharm Exec looks at the factors contributing to the strategic dominance of these regions.
April 10, 2014
Features
0
0
The Healthcare Businesswomen's Association honored three female leaders this year. We take an in-depth look at each winner's background and career-and what factors helped push them to the top of their game.
April 01, 2014
Column
0
0
Three strategic implications for pharma pricing strategies in India.
April 01, 2014
Column
0
0
The plan to accelerate generic pricing and reimbursement has become another tragic European casualty.
April 01, 2014
From the Editor
0
0
Three examples from Pharm Exec's coverage this month show that, in our industry, there are always two sides-at least-to every question.